Multidrug Resistance Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial
DiscussionThe lack of a safe and effective regimen that can be used in all patients is a major obstacle to delivering appropriate treatment to all patients with active MDR/RR-TB. Identifying multiple shorter, safe, and effective regimens has the potential to greatly reduce the burden of this deadly disease worldwide.Trial registrationClinicalTrials.gov Identifier NCT02754765. Registered on 28 April 2016; the record was last updated for study protocol version 3.3, on 27 August 2019. (Source: Trials)
Source: Trials - September 25, 2021 Category: Research Source Type: clinical trials
Epidemiological Investigation of Sepsis in Obstetrics Admitted to ICU
Conditions: Maternal Sepsis; Intensive Care Units; Drug Resistance, Multiple Intervention: Other: Multidrug-resistant bacteria Sponsors: Peking University Third Hospital; Beijing Chao Yang Hospital; Beijing Friendship Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2021 Category: Research Source Type: clinical trials
